#160853

VLS-VSCC cell line

Cat. #160853

VLS-VSCC cell line

Cat. #: 160853

Unit size: 1x10^6 cells / vial

Organism: Human

Disease: Cancer

Model: Cancer Model

£575.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Inventor: Daniela Elena Costea ; Harsh Dongre ; Line Bj̙rge

Institute: Haukeland University Hospital; University of Bergen

Tool Details
Applications
Handling
References

Tool Details

*FOR RESEARCH USE ONLY

  • Name: VLS-VSCC cell line
  • Alternate name: UB-VCC1
  • Organism: Human
  • Disease: Cancer
  • Growth properties: Doubling time: 18.90 Â?„Â… 0.53 hours
  • Model: Cancer Model
  • Conditional: No
  • Description: A novel spontaneously immortalized cell line established from vulva squamous cell carcinoma associated with lichen sclerosus. Currently, there are no in vitro models to study VSCC-VLS. This is the first cell line modelling this disease.
  • Production details: Spontaneously immortalized, i.e without any additional genetic alterations
  • Cellosaurus id: CVCL_YD88

Applications

  • Application notes: CVCL_YD88

Handling

  • Format: Frozen
  • Growth medium: Spontaneously immortalized, i.e without any additional genetic alterations DMEM/Nutrient Mixture F-12 Ham medium (D8437, Sigma) supplemented with 10% NBCS, 1X Insulin-Transferrin-Selenium (41400-04, Thermofisher Scientific), 0.4 ug/mL hydrocortisone (H0888, Sigma), 50ug/mL L-ascorbic acid (A7631, Sigma), and 10ng/mL epidermal growth factor (E9644, Sigma) Doubling time: 18.90 Â?„Â… 0.53 hours
  • Unit size: 1x10^6 cells / vial

References

  • Dongre et al. 2020. Exp Cell Res. 386(1):111684. PMID: 31654625.